NCT05771896 Darolutamide With Radium-223 or Placebo and the Effect on Radiological Progression-Free Survival for Patients With mCSPC Status WITHDRAWN Phase PHASE3
NCT05751941 Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05717582 Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment Status NOT_YET_RECRUITING Phase PHASE2
NCT05590793 Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate Status COMPLETED Phase PHASE3
NCT05582772 TOward a comPrehensive Supportive Care Intervention for Older Men With Metastatic Prostate Cancer Status RECRUITING Phase NA
NCT05471427 Predictive fActors for toleraNce to Taxane Based CHemotherapy In Older adultS Affected by mEtastatic Prostate Cancer Status COMPLETED Phase N/A
NCT05415787 Evaluation of the Technical Feasibility of Testing ct DNA for Homologous Recombination Gene Variants in Metastatic Prostate Cancer. Status COMPLETED Phase N/A
NCT05413421 Study of ORIC-944 in Patients With Metastatic Prostate Cancer Status RECRUITING Phase PHASE1
NCT05404139 Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT) Status RECRUITING Phase PHASE2
NCT05367440 Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05167175 The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation Status UNKNOWN Phase PHASE2
NCT05156372 Adjuvant High-intensity Interval Training During Chemotherapy in Metastatic Prostate Cancer Patients Status WITHDRAWN Phase NA
NCT05127850 MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate Cancer Status COMPLETED Phase NA
NCT05011383 High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers Status RECRUITING Phase PHASE2
NCT04926155 The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer Status UNKNOWN Phase PHASE2
NCT04925648 Psma Intensity Can be Altered by Androgen and Phospho-SrC Obstruction Status COMPLETED Phase PHASE2
NCT04925063 The Effect of Metformin in Patients With Newly Diagnosed mHSPC Status NOT_YET_RECRUITING Phase PHASE2